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Binding of the antigen receptor on T cells initiates a rapid series of signaling events 
leading to an immune response. To fully understand T cell mediated immunity, 
underlying regulatory properties of the receptor network must be understood. Monitoring 
dynamic protein signaling events allows for network analysis. Unfortunately, dynamic 
data acquisition is often extremely time-consuming and expensive with conventional 
methods; the number of proteins monitored at the same time on the same sample is 
limited. Furthermore, with conventional, multi-well plate assays it is difficult to achieve 
adequate resolution at sub-minute timescales.  Microfluidics is a capable alternative, 
providing uniformity in sample handling to reduce error between experiments and 
precision in timing, an important factor in monitoring phosphorylation events that occur 
within minutes of stimulation. We used a two-module microfluidic platform for 
simultaneous multi-time point stimulation and lysis of T cells to investigate early 
signaling events with a resolution down to 20 seconds using only small amounts of cells 
and reagents. The device did not elicit adverse cellular stress in Jurkat cells.  The 
activation of 6 important proteins in the signaling cascade upon stimulation with a 
soluble form of α-CD3 in the device was quantified and compared under a variety of 
conditions.  First, in comparison to manual pipetting, the microdevice exhibits 
significantly less error between experiments. Secondly, a comparison between Jurkat 
cells and primary T cells shows similar dynamic trends across the 6 proteins. Finally, we 
have used the device to compare properties of long-term vs short-term cultured primary T 
cells. As expected, older cells present a much weakened response to antigenic cues, as 
 xii 
measured with TCR response markers. This modular microdevice provides a flexible 










1.1.1 Importance of T Cell signaling 
The human immune system is composed of a collection of different cell types, working together to 
protect our bodies from bacterial, parasitic, fungal or viral infections, and against the growth of 
tumors. The process starts with the recognition of an antigen, which is displayed on the surface of a 
cell. If the antigen is recognized as “non-self”, the immune system will induce a signaling cascade to 
kill the invader. The first step of this immune response is made by the innate immune system, 
macrophages or dendritic cells. If the innate system can not fight against the pathogen by itself, they 
will become antigen presenting cells and activate T cells, lymphocytes from the thymus. The 
presentation of the antigen generates an immunological synapse. The presentation must be long 
enough to enable the mounting of an immune response, but not too long, otherwise the T-cell will 
undergo apoptosis. T cell receptor (TCR) activation, in naïve T cells, drives their differentiation and 
expansion. In mature T cells, it will drive expansion and triggering of effector functions, such as 
cytokine synthesis or cytotoxicity. (Nel, 2002) 
A defect in T cell signaling leads to a large number of diseases. Autoimmune diseases and 
lymphoproliferative diseases such as multiple sclerosis, rheumatoid arthritis, lupus, type 1 diabetes, 
autoimmune lymphoproliferative syndrome (ALPS), come from a disruption of the surveillance 
mechanism leading to the tolerance of T cells to self-antigens. These T cells with high affinity for self 
peptide MHC do not undergo programmed cell death and usually escape functional inactivation 
(anergy) or extrathymic deletion. Inappropriate activation of these auto-reactive T cells leads to 
destruction of tissues and very serious diseases. (Abbas 2002, Peggs et al 2008) 
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Some viruses, such as HIV, use T cells as their major site of infection and replication, and inhibit the 
ability of these cells to respond. (Jerome 2008) 
1.1.2 Quantification of T cell properties for cancer 
Immune-based therapies hold promise in cancer therapy by harnessing the body’s natural defense 
mechanisms against tumors. One approach, adoptive T cell therapy, is currently being investigated for 
clinical feasibility. A challenge in translating adoptive T cell therapy into a useful tool for oncologists 
is the ability for tumor antigen-specific T cells to maintain functionality after expansion and once in 
the tumor environment. Before adoptive transfer, T cell clones are evaluated based upon their 
specificity or their functionality. Functionality is quantified by cytokine production or cytolytic 
activity. Although specificity is retained in vivo, exhaustion of T cells from culturing can result in 
anergy. In addition, tumor cells can also cause anergy in vivo by several inhibitory mechanisms. In 
order to continue clinical development of this immune-based therapy, there is a need for assays to 
establish the level of responsiveness ex vivo and in vivo to monitor the state of the transferred T cells.  
Adoptive transfer therapy by transfusion of T lymphocytes into cancer patients has held promise for 
many years as a method of harnessing the power of the adaptive immune response for fighting tumors 
as “foreign” bodies. Landmark studies of adoptive transfer for treating metastatic melanoma (Yee et al 
2000; Dudley et al 2002) have resulted in a number of additional applications to pursue clinical trials 
for metastatic melanoma as well as prostate cancer, non-Hodgkin’s lymphoma, chronic lymphocytic 
leukemia, nasopharyngeal carcinoma, lung cancer, gastric cancer and renal cell carcinoma (June 2007). 
Many of the clinical trials currently underway utilize autologous T cells that are refined for their 
specificity or engineered to enhance their activity in vivo (Morgan et al 2006).  The use of T cell 
clones for adoptive transfer allows for selective expansion for tumor antigens. The transfer of peptide-
primed CD4+ clones has been found to enhance the anti-tumor immunoresponse (Ossendorp et al 
1998), most likely due to their cytokine-mediated recruitment of other immune cells. Both CD8+ and 
CD4+ cells are susceptible to loss of effector function in vivo (Staveley-O'Carroll et al 1998; Zippelius 
et al 2004). Immune suppression due to tumors remains a significant obstacle in the development of 
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adoptive therapy treatment protocols (Matter et al 2007). Many mechanisms have been uncovered by 
which tumors evade recognition and tolerize T cells. Tolerization is induced in part by an imbalance 
between stimulatory co-receptors such as B7.1 and B7.2 and inhibitory co-receptors such as CTLA-4 
(present on Tregs), B7-H1, and B7-H4 in the tumor microenvironment (Zou 2005).  
Before an effective T cell transfer, T cell functionality must be evaluated prior to infusion into patients. 
The assessment of T cell responsiveness ex vivo, therefore, is the motivation for the work presented in 
this document. 
1.1.3   Development of microfluidic devices 
Microfluidics technology has emerged as an attractive method of sampling molecular processes due to 
the controlled environmental conditions and small analyte and/or reagent volumes needed. In addition 
to the traditional advantages associated with miniaturization, fluids at the microscale exhibits very 
interesting properties. In microscale environments, certain fluid phemomena such as laminar flow, 
surface tension dominating over body forces, fluidic resistance, diffusion or energy dissipation become 
more pronounced. (Bebee, 2002)  
Laminar flow is deterministic and especially predictable. It means that for a specific time point, we are 
able to predict the position of a particle of fluid in a particular stream. Flow in microfluidics is 
characterized by low Reynolds Number (
µ
ρvL
=Re , where ρ is the density of the fluid, v its velocity, 
L the characteristic length of the channel, and µ, the viscosity of the fluid), usually less than 10. In a 
context of laminar flow, streams in contact with each other will not mix except by passive diffusion, 
enabling an easy production of concentration gradients. If grooves or any other 3D microstructure are 
in the channels, the flow can become chaotic, thus enhancing mass transport (Whitesides 2006, 
Stroock 2002)  
Micromachining of silicon or glass was the first fabrication process used to create microfluidic 
devices. Cheaper techniques as soft lithography of polymers, such as PDMS, appeared to enable the 
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expansion and the use of microfluidics for biological applications. Nowadays, a large number of 
biological assays exist on lab on a chip, such as DNA electrophoresis, enzyme assays, immunoassays 
(Groissman et al 2005, Paliwal et al 2007, King et al 2008, El-Ali et al 2007, Lu et al 2005, McClain 
et al 2005, Sims et al 2007, Lee et al 2006, Herr et al 2007)  
The use of microfluidics for these assays, in addition to the small reagent consumption, provides 
uniformity in sample handling to reduce error between experiments. It is also particularly suitable for 
high-throughput analysis and automation (Thorsen et al 2002; Lee et al 2005).   
1.2 Prior knowledge 
1.2.1 Capturing cell responsiveness: State of Art 
1.2.1.1 Conventional Techniques 
The measure of the frequency of cytokine secretion with enzyme-linked immunospot (ELISPOT) is a 
general test to assess cell responsiveness (Dang et al 2007). Unfortunately, it can not be multiplexed 
and usually takes hours to perform. Furthermore, it is not able to correlate cytokine production in real 
time to protein activation dynamics.  
Flow cytometry analysis of intracellular cytokine production after 4 hours of PMA (Phorbol 12- 
myristate 13-acetate) or antigen presenting cell exposure is also used to assess response by staining 
fixed, permeablized cells with anti-cytokine antibodies. Activation-induced cell death metrics (e.g. 
anti-caspase 8) can also be quantified in this manner. Advantages of flow cytometry are the small 
number of cells needed for analysis and the ability to identify population heterogeneity by the single-
cell analysis. A disadvantage is the number of measurements that can be made in parallel is limited by 
instrumentation. 
Recently, others have recognized the ability of using early activation events to evaluate T cell 
functionality. TCR downregulation occurs within minutes of T cell activation, and was used in one 
report to assess responsiveness efficiency of T cells by flow cytometry (Kohrt et al 2005). This 
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protocol, however, relied on 4 hours of stimulation before quantifying this early activation event. 
Moreover, the multi-laser cytometers are constrained for the number of proteins monitored on the 
same sample.  
Cell lysis and biochemical detection of population averages remains the most widespread method of 
capturing intracellular signaling dynamics of protein pathways. To extract the necessary protein 
information the cell must be stimulated for a precise period of time and immediately lysed to extract 
intracellular proteins for downstream analysis. With conventional, multi-well plate assays it is difficult 
to achieve adequate resolution at sub-minute timescales.  
1.2.1.2 Prior Microfluidic Devices 
Many microdevices have been reported for culturing cells, stimulating with soluble factors, assaying 
gene expression and performing lysis (Whitesides 2006).  The challenges of any on-chip assays are 
that the devices should minimize stress on the cells, should provide reproducible results, from 
experiment to experiment, should produce quantitative results comparable to or better than bench-top 
schemes, should be scalable to high throughput format, should minimize consumption of cells and 
reagents, and ideally provide the temporal resolution that the bench-top counterparts cannot achieve.  
 
Cell lysis on chip has been performed by many different ways: chemically, mechanically, electrically 
or thermally. The chemical method is the most common. The main advantage of chemical lysis is that 
subsequent assays can be performed in buffers previously optimized for conventional biological 
studies (El-Ali et al, 2007),  using surfactants that solubilize the lipid membranes. Carlo et al presented 
cell lysis on chip based on local hydroxide electro generation (Carlo et al 2005). To help with the 
dilution of the lysate in solution, some groups performed lysis of single cells in picoliters reactors 
(Irimia et al 2005, Wu et al 2004). Mechanical lysis of cells has been performed on a compact disk 
with the centrifugal forces (Kim et al 2004) or just by increasing shear forces on the surfaces of the 
cells. Electrical lysis is attractive because of its rapidity and lack of reagent. (Wang et al, 2006) 
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Previously El-Ali et al developed a device achieving cell stimulus and lysis on a microfluidic chip 
using segmented gas-liquid flow for rapid mixing (El-Ali 2005).  This device was the first to 
demonstrate on-chip multiple step manipulation of cells with fast mixing, thereby allowing access to 
the early time-point detection of protein states. They looked at the dynamics of 3 proteins downstream 
TCR ligation, ERK, JNK and p38, and showed that a time delay of about 45 seconds appeared to exist 
between TCR activation and activation of these kinases. However, segmented gas-liquid flow induces 
a significant shear stress on the cells at the interface. Their range of activation was performed by 
changing the flow rate, and ranged from 10seconds to 160 seconds; however, it does not enable a 
parallel acquisition of data from multi time points, and the range of stimulation time is limited. 
 
1.2.2 Background in TCR signaling 
The T cell antigen receptor (TCR) is a recognition module on the T cell surface, composed of an αβ-
heterodimer or a γδ-heterodimer, and a signal transducing module containing CD3ε, CD3δ, CD3γ and 
CD3ζ polypeptides. The recognition of peptides bound to the major histocompatibility complex 
(MHC) by the TCR leads to the transduction of signals across the plasma membrane, and to the 
induction of cellular responses involved in T-lymphocyte effector function (Davis et al, 1998; Weiss & 
Littman, 1994). An early and essential signaling event that occurs after TCR ligation is the 
phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs), which are located in 
the cytoplasmic domains of the CD3 subunits, by the Src kinase Lck.  
Lck phosphorylation results in the recruitment and activation of ζ-chain-associated protein kinase 
70kDa (ZAP70), which binds to the phosphorylated ITAMs. Once bound, Zap70, in turn, 
phosphorylates LAT, a transmembrane protein with 10 sites of potential tyrosine phosphorylation. 
Phosphorylation of the C-terminal four sites allows binding and activation of a set of adapter 
molecules, including phospholipase Cγ (PLC-γ), growth factor receptor-bound protein 2 (Grb2), and 
Grb2-related adaptor downstream of Shc (GADS). The activation of the adopter molecules GADS and 
Grb2, linked to the adapter protein LAT, leads to the activation of Ras, and the mitogen activated 
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protein kinases (MAPKs), such as ERK. The recruitment of GADS to LAT facilitates also the 
phosphorylation of SLP76 and association with Vav. This leads to cytoskeletal arrangements at the 
immunological synapse for further signal propagation. 
The binding and activation of PLC-γ and the adapter molecules GADS and Grb2 lead to the 
recruitment of additional molecules and/or the triggering of downstream signaling events. Activated 
PLC-γ cleaves phosphatidylinositol biphosphate (PIP2) to diacylglycerol (DAG) and inositol 
triphosphate (IP3). It leads to the release of Ca
2+
 from the endoplasmic reticulum. DAG activates 
protein kinase C (PKC), which leads to the nuclear translocation of the transcription factor NF-kB.  
A new recent signaling pathway independent on LAT has been recently described. (Salvador et al, 
2005). This alternative pathway involves activation of the kinase p38, which may be directly 
phosphorylated by ZAP-70. p38-dependent TCR signaling appears to favor a predominantly Th2-type 
response, characterized by synthesis of cytokines such as interleukin- 4 (IL-4), IL-5, IL-13 and, 
especially, IL-10. 
Costimulatory receptors also plays a big role in initiating an immune response. CD28 is one of the 
most studied ones. In the absence of CD28 costimulation, TCR ligation induces a much weakened 
response that can lead to anergy. CTLA-4 (which has the same ligands as CD28), or PD-1 
(programmed cell death receptor 1) are inhibitory co-receptors, inducing the activation of phosphatases 
such as PP2A (protein phosphatase 2A), Shp-1 or Shp-2, that dephosphorylate molecules within the 
TCR pathway. (Song et al 2008) 
Kemp et al demonstrated the suitability of studying T cell receptor signaling downstream of the 
receptor by sampling across the entire kinase network, by generating a dataset of 1100 measurements 
to represent signaling and response of TCR activation by measuring the dynamics of activation under 
different altered peptide ligand stimulation conditions. Through time-dependent data acquisition, the 
quantitative propagation of varied ligand avidity from altered peptide ligands was correlated to the 
magnitude of cytokine response by IL-2 production with a partial least squares regression model. This 
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model quantitatively established the combined contributions of each kinase cascade to IL-2 as shown 
by experimentally verified predictions of Erk and Akt inhibition.  
1.2.3 Senescence in T-Cell activity 
Adoptive transfer therapy relies on large quantities of T cells that maintain effector function. Because 
the adoptive transfer of senescent cells will result in suboptimal outcomes (or completely failure to 
curb tumor growth), a standardized method that can quantitatively evaluate the sensitivity of T cells to 
antigenic cues will improve the consistency of immune-based therapies in cancer treatment.  
Senescence designates the dysregulation and dysfunction of cellular processes associated with age. For 
immune cells, it is often associated with a weakened response to antigenic cues, leading to a complete 
lack of response. This deterioration of immune response is thought to be linked in the elderly with a 
higher susceptibility to have cancer, autoimmune diseases or infectious diseases (e.g. pneumonia, 
influenza, bronchitis) (Pawalec et al, 2000).  
Senescence is also observed in cultured cells. In 1961, for the first time, Hayflick and Moorehead 
reported that cultured human fibroblasts have a limited lifespan. All somatic cells undergo a finite and 
predictable number of cell division before reaching an irreversible state of growth arrest. This Hayflick 
limit is inherent to the cell type. (Hayflick 1985) 
Pawalec et al (2000) have showed that T cell clones, after a certain number of passages, have a 
decreased ability to undergo autocrine clonal expansion and a decreased production of IL-2. They 
showed some alterations in surface molecules, like the co-stimulatory CD28, which could explain their 
altered responsiveness to activation signals. Furthermore, old cells are more susceptible to undergo 
apoptosis instead of tolerance or response, after stimulation because the levels of anti-apoptotic protein 
bcl-2 decreases. More recently, Mazzati et al (Aging Cell, 2007) investigated which genes and 
signaling pathways were differentially expressed in immunosenescence. Differences in expression of 
the transcriptional factor AP-1 and Fos, a part of the heterodimeric AP-1 transcription factor, involved 
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in cellular proliferation, differentiation and inflammation are found in senescent cells. They also show 
upregulation of proteins implicated in apoptosis, such as PTPN13, which has a role in FAS ligand 
mediated apoptosis, and lymphotoxin B, involved in tumor necrosis factor associated factor dependent 
caspase independent apoptosis. Using mass spectometry, the authors identified profilin-1, a ubiquitous 
protein associated with actin remodeling and cellular motility, as an unambiguously identified protein 
that gets overexpressed in senescent T cells (2007, Proteome Science). A decreased membrane fluidity 
and calcium influx and an altered regulation of the redox sensitive transcriptional factor NFκB, are 
also associated with senescence.  
1.3 Outline of thesis 
It is very important to be able to evaluate the responsiveness ex vivo-expanded T cells accurately for 
cancer therapy. Capturing the early dynamics of T cell activation of ex vivo expanded clones would 
improve upon current measures of T cell functionality. This measurement would be optimal for 
evaluating whether transferred T cells have retained their response to antigenic stimulation under 
culture conditions. The microfluidic format requires small sample and enables high-throughput 
experiments, in turn providing the much needed feedback on the quality of T cell therapy during 
cancer treatment.  
A microfluidic system has been designed to capture T cell activation at many time points, especially 
immediately within minutes after the stimulation, on a small population of cells.  To demonstrate 
feasibility of using minute amounts of samples from the microfluidic assay, protein yield and activities 
were determined by biochemical assays.  In addition, we measured cell stress responses to validate that 
the microfluidic assays are not changing the biochemical properties of the cells non-specifically.  The 
first set of assays was performed on an immortalized cell line to help optimizing experimental 
conditions, but also to establish a set of baseline parameters that cells from donors can be compared to. 
We used primary human T cells that are either anergic by senescence or capable of being activated to 
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A PARALLEL MULTI-TIME POINT MICROFLUIDIC DEVICE FOR CELL 
STIMULATION AND LYSIS 
 
 The study of signaling pathways requires the collection of data with a very good time 
resolution. One may be interested in protein activation, mRNA expression, but in all cases, a 
controlled stimulation time and fast lysis have to occur. Microfluidics is a very good tool to achieve 
this temporal resolution, as the laminar behavior of the fluid enables a precise control of residence time 
and the automated process provides uniformity in sample handling to reduce errors between 
experiments.   
2.1 Microfluidic system with rapid mixing, controlled stimulation and lysis of cells: Design 
and Characterization 
The design and characterization of the device was performed by Alison Hirsch in the School of 
Chemical and Biomolecular Engineering. 
 
Previously El-Ali et al. developed a device achieving cell stimulus and lysis on a microfluidic chip 
using segmented gas-liquid flow for rapid mixing (2005).  This device demonstrated fast mixing and 
early time-point detection of protein states.  However, it did not enable a range of different incubation 
periods to understand the dynamics of multiple proteins upon stimulation. The device used in this 
thesis work was designed to complete 8 time points in parallel with controlled rapid mixing, precisely 
timed stimulation, and rapid lysis. 
 
A two-module approach was used.  Cell-containing media and stimulus solution enter in the first 
module by 2 separate inlets, with the flow driven by pressure with syringe pumps. They are mixed and 
split into 8 equal streams.  The majority of the incubation time occurs in the tubing leading to module 
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2.  On module 2, the reaction is quenched and cells are lysed by mixing with cold lysis buffer to 
extract intracellular components. The total amount of reagents used for these 8 time-point sample 
collection includes only 1.3 mL of cell suspension and lysis buffer, and 0.7 mL of stimulus.  
 
To ensure a precise definition of stimulation time, especially for the very early time points (e.g. 20 
seconds), rapid mixing of cells with stimulus and lysis buffer is essential. If mixing takes a significant 
portion of the time compared to stimulation and lysis incubation, cells suspended in the initial medium 
will be immersed in the stimulant for different times, and the contact time cannot be precisely 
controlled.   
 
The asymmetric herringbone mixer (HBM), developed by Stroock et al (2002), has been chosen as a 
fast, low-shear and flowrate-independent mixer. In order to design proper mixers for our application 
and determine an accurate starting time of incubation, Alison Hirsch developed computational fluid 
dynamics (CFD) models for different geometries and experimental flow conditions using COMSOL, a 
finite element solver for non-linear partial differential equations.  Because the buffers, cell solutions, 
and stimulation solutions can have different fluid properties, the model was also used to probe the 
Fig. 1 A schematic of the devices showing inlets, tubing, 
pressure drop channels, and cell lysate outlets for sample 
collection.  The respective residence times (t) in each unit are 
noted in red boxes on the figure, where the total time is 
essentially the time in the tubings, varying with length (L),  inner 
diameter (ID), and volumetric flow rate (Q).  Insets show (a) a 
close-up of Module 1 and (b) the whole device setup. 
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effects of viscosity and density on mixing.  Further confocal microscopy experiments were used to 
visualize the mixing of solutions with mismatched properties.  
 
 
Experimental and computational results for mixing of solutions with the same viscosity, mimicking 
cell and stimulus mixing conditions, suggest that most cells would come into contact with the stimulus 
after 6 cycles. After 9 cycles, the solutions are completely mixed. In contrast, when solutions with 
mismatched viscosity and density are mixed (as in the case of mixing cell suspension with lysis buffer) 
with the same HBM the streamline profiles and extent of mixing are qualitatively different.  In this 
case, the mixing is slower and therefore less efficient. However, this effect occurs only at viscosity 
ratio above that of our experimental conditions and therefore the HBM is adequate for fast mixing of 
cells and stimulus in Module 1, and of cells and lysis buffer in Module 2. 
 
With the channel dimensions and fluid flow rates of the optimized setup, the staggered herringbone 
array achieves full mixing of reagents with minimal shear in less than 0.2 seconds on the stimulation 
chip , and <0.9 seconds on the lysis chip.  These times are less than 5 percent of the ~23-second 
Fig. 2 a) One cycle schematic of the HBM.  (b-d) Comparison of COMSOL model results with experiment.  
(b) perspective view of  the mixing for 1 cycle of herringbone mixers. (c) y-z plane of the concentration 
profile color map from the model after 1 cycle.  (d) y-z view of a confocal image of mixing after a single 
cycle with one inlet containing rhodamine dye.  (e) y-z mixing profile after 6 and 9 cycles.  The scale bar is 
20 µm, twice the average diameter of a T-cell. f) Confocal images of the cross section at increasing mixing 




stimulation time, which was the shortest stimulation time in our experiments.  Hence the mixing time 
does not significantly affect the time point data. 
 
After mixing, the fluid is split into 8 streams on Module 1, each stream accomplishing a different time 
point by using interchangeable tubing of different lengths and diameters.  To obtain an equal flow rates 
in each stream, long pressure drop channels were added to balance the channel resistance.  
 
2.2.  Microfluidic Device Fabrication Process 
The two module device is fabricated using standard soft lithography technique (Xia, 1998). The 
modules are molded in poly(dimethyl-siloxane) (PDMS) (Dow Corning Sylgard 184, Essex-
Brownwell Inc., McDonough, Ga) from a two layer SU-8 (Microchem Corp., Newton, MA) master. 
One layer of 50 µm thick SU-8 2050 was spun onto 100mm silicon wafer, baked, and exposed under 
UV light to define a negative image of the channel system in the resist.  After baking to crosslink the 
exposed resist, another layer of 15 µm thick SU-8 2010 was spun ontop.  This layer formed the 
staggered herringbone array.  After the same bake and expose process, the wafers were developed 
using propylene glycol monomethyl ether acetate (Doe & Ingalls, Inc., Durham NC).  The wafer was 
surface treated with tridecafluoro-1,1,2,2-tetrahydrooctyl-1-trichlorosilane (United Chemical 
Technologies, Inc, Bristol PA) for surface passivation. Then PDMS was molded on the SU-8 master 
for 2 h at 70 
o
C.  The PDMS was peeled off the mold and individual devices were cut to size.  Medical 
grade polyethylene (PE) tubing (Scientific Commodities, Lake Havasu City, AZ) of various lengths 
and inner diameters were used to for fluidic connections.  Holes for fluidic connections were punched 
to a size determined by the outer diameter of the appropriate tubing (21, 18, and 19 gauge for PE-1, -2, 
and -3 respectively).  
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Photoresist patterned via 2 layer 
photolithography 
Spincoat photoresist 
Cast PDMS onto mold and cure 
Plasma bond 
 Fig 3. Adapted from Alison Hirsch. Standard Soft Lithography Process 
The photoresist is first spun onto a silicon wafer, patterned with a dark field mask, in a two layer process. 
After silanization, degassed PDMS is poured onto the silicon wafer and baked at 70°C for 3 hours. The 




PARALLEL ON-CHIP EXPERIMENTS FOR HIGH-THROUGHPUT MULTI-
TIME POINT PROTEIN ACTIVATION ASSAYS 
Understanding the dynamics of cell signaling networks is important to many biological applications, 
especially in complex disease phenotypes related to cancer, immune responses, development, and 
potential pharmacological interferences. Pathways involved in cell maintenance and apoptosis are 
studied extensively to understand cancer development (Janes et al, 2005, Reya et al, 2005).  Focus on 
particular signal-transduction cascades and molecules has provided system-level insights into 
mechanism-based drug discovery (Sands, 2000, Gibbs, 2000) 
 Building a system-level computational model and gaining insights in to the complex signaling 
networks requires large data sets, presently a bottleneck in the process.  For example, gene expression 
patterns or protein activity at various time points during stimulation with an external signal must be 
known; it usually takes many labs years to accumulate a large body of this type of data (Gaudet et al, 
2005, Schoeberl et al, 2002, Kemp et al, 2007).  Another challenge in signaling research is that many 
of these important protein activation events, such as phosphorylation, occur within minutes after 
stimulation (Kohrt et al, 2005, Kholodenko et al, 1999, Germain et al, 1999).  Quantitative data not 
only at precise time points but early in the cells’ response are necessary for accurate model generation.  
3.1 Device operation and reliability 
3.1.1 Cell distribution 
3.1.1.1 Methods 
For this study, we used Jurkat E6-1 human acute T-cell lymphoma from ATCC. Cells were cultured in 
RPMI 1640 medium with L-glutamine (Sigma-Aldrich) with 10 mM HEPES, 1mM Sodium Pyruvate, 
1X MEM Nonessential Amino Acids, and 100 units/mL penicillin streptomycin (Cellgro), 
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supplemented with 10% certified heat inactivated fetal bovine serum (Sigma-Aldrich) at 37 °C in a 
humidified 5% CO2 incubator.  
For the experiments, Jurkat E6-1 cells were resuspended in a phenol-red free RPMI 1640 medium 
(Sigma-Aldrich), supplemented with the previous reagents and 0.3 mg/ml of L-Glutamine (VWR). To 
prevent cell settling in the syringe, a 7wt % dextran powder was added to the prepared solution.  
Before each experiment, each module was sterilized by flowing ethanol and water through it. Each 
microfluidic device was used only once.  
After the cells were flowed through the microfluidic device, cells were counted with a 
hematocytometer. 
  
3.1.1.2 Results and Discussion 
Although fluid flow distribution was equal, cells were often observed to settle and aggregate. These 
aggregations in turn caused blockage on chips and together with settling, causing the cell distribution 
in the 8 collected samples to be non-uniform and unpredictable.  
 
 To resolve this issue, the media and stimulation solutions were supplemented with dextran to match 
the density of the cells (approx. 1.07 g/cm
3
).  In addition, dextran may also contribute to the 
suppression of unspecific adsorption of serum proteins in the medium which promotes cell adhesion to 
the walls. To determine the cell distribution after Module 1, regular medium was flown through the 
first inlet and cells at a known concentration, suspended in medium in the second inlet, both 
supplemented with dextran.  The suspension in each outlet was collected and cells were counted with a 
hematocytometer to determine cell concentration.  The average standard deviation of cell density in 
each stream was decreased by more than half compared to similar experiments without dextran. In 
addition, by taking the cells lost to settling in the syringes and devices into account, the resulting 
improvement by adding dextran is very significant.   





Nevertheless, variability between cell concentrations per stream still exists. The addition of dextran 































Fig. 4 The average standard deviation of cell concentration in each stream with and without dextran 
supplement in the solutions.  The standard deviation between experiments is decreased by half with the 
addition of dextran and percent cell loss is markedly decreased. 
Fig. 5 Predictable but uneven split of cells within the first module 
after addition of dextran 
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Fig. 6 Cell Distribution after the split in the first module for different number of herringbone cycles . 
 
In an attempt to improve the distribution, we changed the number of cycles of the herringbones (Figure 
6). In fact, a simple channel splitting in 8 equal channels gives an even distribution of flow rates, but 
also of cells, so that we can confirm that the majority of cells follow the streamlines. The addition of 
herringbones changes the folding of the fluid and thus has an impact on the cell behaviour. None of 
our attempts to get a more even distribution was successful. Ten cycles of herringbones shifted the 
majority of the cells to the outlet 7. Eleven cycles was quite similar to 9 cycles, because it showed two 
peaks at outlet number 2 and 7, but the standard deviation between the outlets with the majority of the 
cells and the others was much more pronounced. Twelve cycles was similar to 10 cycles, and 13 cycles 
to 11 cycles. We could not try less than 9 herringbone cycles, which is the minimum number of cycles 
to make sure our reagents are mixed properly. It is very difficult to model the trajectories of particles 
in a channel with herringbone structures, without being limited by the computational power required. 
Attempts to use COMSOL, and its particle tracking tool to predict cell trajectories failed. The number 
of herringbone cycles seems to play a role in the cell distribution but we have not been able so far to 
understand how the cells behave in this structure. The distribution with 9 cycles being the more 




We tried then to see the impact of the flow rates on the cell distribution, reasoning that with a slower 
flow rate, the cells would follow more easily the streamlines. (Figure 7) 
For this experiment, we used the 9 cycles HB device and modified the flow rate from 6.66 µL/min to 
20 µL /min. This range was limited by the residence time in the mixing part compared to our smallest 
time points, and by the time we wanted the experiment to last. The maximum flow rate was chosen 
accordingly to the maximum shear stress the cell could bear before being activated.  
 
 
Changing the flow rate did not significantly enhance our distribution pattern. The slower flow rate 
gave us three peaks instead of 2 but the distribution was more unpredictable and the experiment much 
longer, which may induce errors if all the cells are left too long in the syringes (settling can occur even 
in the presence of dextran, cell death because of lack of nutrients and different lysis time). Faster 
flowrate increases shear stress on the cells and did not really improve the distribution, so the previous 
flow rate of 10 µL/min was kept for the subsequent experiments. 
 
Fig. 7 Cell Distribution after the split in the first module for different flowrates ranging from 6.66 to 20 µL/min. 
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In another attempt to get a more even distribution, we decided to focus the cells after the HB mixers, 
by pinching the size of the channel before the splitting region. The original channel has a width of 100 
µm and a length of 250 µm after the last cycle of HB before the split. In order not to clog the channel 
with the cells, whose diameter is about 10 µm, the width of the channel before the split has been 
decreased to 50 µm, for 250 µm and 500 µm in length. The pinching channel did not show significant 
improvement (Figure 8). The length after the last cycle of HB seemed to play a bigger role, but 




Fig. 8 Cell Distribution after the split in the first module for not pinched and pinched channel, for a 9 cycles HB 
mixer, and a flow rate of 10 µL/min. A simplified schematic of the pinching of the channel is shown on the top 
right of the picture. 
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From these experiments, we showed that cell distribution in herringbone structure is not trivial. Cells 
get focused in certain positions, and changing the flowrate or the the number of herringbone cycles has 
an effect on this distribution. Alison Hirsch is continuing this work, trying to model cell trajectories in 
simple herringbone structures.  
3.1.2 Correlation between protein and cell distribution 
Because the number of cells in all outlets are not the same, in order to quantify protein activation, we 
needed to be able to normalize for the cell numbers. Total protein concentration is a reasonable choice. 
3.1.2.1 Methods 
To obtain the total protein concentration from each outlet, both modules of the microfluidic device 
were used. In the first module, cells in a 7% dextran supplemented medium were mixed with the same 
medium. The tubings connecting both chips had the same length, as there is no need to obtain several 
time points. In the second chip, cells were mixed with a home-made cold lysis buffer. The lysis buffer 
used in these experiments was based on a 100% NP-40 solution (USBiological), supplemented with 1 
M β-glycerophosphate (Calbiochem), 0.2 M sodium pyrophosphate (Alpha Aesar), 1 M sodium 
fluoride (EMD), 5 M Tris (Promega), 0.2 M sodium orthovanadate (Alfa  Aesar), 5 M sodium chloride 
(Alfa Aesar), 100 mM benzamidine (Sigma), 500 mM EGTA (VWR), 5 mg/ml aprotinin (Sigma), 5 
mg/ml leupeptin (VWR), 1 mg/ml pepsatin (Sigma), 1 mg/ml microcystin-LR (Sigma).  Lysate 
solutions were collected at the outlets of the device, and centrifuged for 10 minutes at 14000rpm to 
remove the pellet. The total protein concentration was determined with a BCA assay kit (Pierce). In 
order not to interfere with the BCA assay kit, the medium used was phenol red and serum free.  
3.1.2.2 Results and Discussion 
The protein concentration obtained followed a distribution pattern very similar to the cells. The protein 
concentration could be correlated to the cell concentration from each outlet with a correlation 
coefficient of 0.85, as shown in Figure 9. To correlate cell and protein concentration from a single 
experiment, cells are first flowed through both devices, mixed two times with regular medium, and 
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collected. To acquire the lysates, the regular medium is switched with lysis buffer in the second 
module. 
Correlation Protein/Cell concentration





























Figure 9 shows that the total protein yield is linearly correlated to the number of cells in the sample, so 
that protein activity data can be easily normalized by the total protein in the sample. Using 5 to 8 
million cells / mL of medium gave a sufficient protein yield, even for the outlets 4 and 5, usually 
devoid of the cells. 
3.1.3 On-chip cell handling showing minimal stress on cells 
For a microfluidic device to perform optimally for signal transduction applications, fluid forces must 
not impose adverse stresses on the cells within the chip. To validate that the cells flowing through the 
device were not subjected to undesirable shear stress due to fluid flow in narrow channels, undesirable 
mechanical forces produced by chaotic mixing, or lack of oxygen perfusion during the course of the 
experiment, the phosphorylation state of two MAPK proteins associated with stress response, p38 and 
JNK, were monitored. 
Fig. 9 Correlation between cell and protein concentration 
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3.1.3.1 Methods 
Cells in dextran-supplemented medium, with no stimulatory reagents, were pumped through both 
modules of the microfluidic device. The lysates were compared to the results from cells lysed on bench 
top, also without any stimulation. For standard bench lysis, the addition was made by pipette addition 
of lysis buffer to microcentrifuge tubes containing the cells. The samples were incubated 30 minutes 
on ice, centrifuged at 14000 rpm for 10 minutes, and further protein analysis was performed with the 
supernatants.  
The analysis of phosphorylation dynamics were performed with a Bio-Plex-200 instrument (Bio-Rad) 
using commercially available Luminex bead assays. The phospho-p38 and phospho-Jnk (Bio-Rad) 
measurements were performed following the manufacturer’s protocol, after loading the same amount 
of protein in all the wells. To assess the success of the protocols, the lysates provided by the 
manufacturer were used as positive controls in the Luminex bead assay. 
3.1.3.2 Results and Discussion 
The levels of p38 and JNK activation for on-chip activation are constant over time and comparable to 
the results obtained on bench, demonstrating that the cells are neither adversely stressed by the 
conditions imposed by the flow through the microchannels, nor stressed by the time spent in the 
tubings (Figure 10). The lysates of Jurkat cells provided by the manufacturer gave similar values for 
the same amount of protein loaded. 
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There was also no noticeable change in cell viability or morphology as observed by trypan blue 
exclusion after cells were subjected to flow through the device.  
3.2 Multi-point TCR activation assay 
3.2.1 Significance 
The temporal regulation of protein activation during T cell receptor signaling involves multiple 
coordinated feedback loops, as reviewed by Germain et al (1999). Prior proteomic studies indicate 
widespread phosphorylation of signaling molecules occur within 5 minutes of T cell activation (Kim 
and White, 2006); thus, a method for consistent generation of sub-minute signaling events would be 
useful for extracting relationships between interconnected network components. To ensure that the 
microfluidic system is a reliable method of evaluating T cell activation, we characterized the 
Fig. 10 Activated JNK and p38 concentrations in cells collected from the microfluidic devices 
compared to on bench controls, showing now signs of cellular stress induced by the device. For this 
experiment, samples were normalized to total cellular protein content. The experiments were run with 
three different devices and then the protein phosphorylation quantification was obtained with 
duplicates. Dashed lines represent the quantified values for phospho-p38 and phospho-JNK from 
control samples lysed on the bench. Dotted lines indicate standard deviation associated with the 
control values.  Mean fluorescence intensity measurements for positive controls were comparable in 
magnitude to positive control lysates supplied by the manufacturer. 
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3.2.2 TCR activation in Jurkat Cells: Methods, Results and Discussion 
Lysates were obtained from modules 1 and 2, with Jurkat cells treated with anti-human CD3, clone 
OKT3 (eBiosciences) at a final concentration of 2 µg/ml. To compare the efficiency of our micofluidic 
device, we have generated on bench standard stimulated lysates, as explained in the section 3.1.3.1.  
Comparisons between anti-CD3 (OKT3) stimulated Jurkat lysates generated by standard bench-top 
protocol and those generated by the device were made using the Beadlyte 7-plex human T-Cell 
receptor phosphoprotein signaling kit (Upstate). This kit quantifies phosphorylated ITAMs (CD3ε), 
ZAP-70, Lck, LAT, Erk, and CREB using the Luminex instrument as described by Khan et al (2007). 
Jurkat cells in a 7% dextran, phenol red and serum free medium were stimulated with the soluble form 
of anti-CD3 for the incubation times ranging approximately from 20 seconds to 4.5 minutes and then 
lysed with a cold lysis buffer containing phosphatase and protease inhibitors that prevent further 
biochemical events after lysis. The quantification of activated proteins downstream the TCR were 
Fig. 11 Simplified pathway of TCR activation. After a peptide MHC has bound to 
the CD3/TCR complex , Lck phosphorylates the ITAM CD3, that recruits the 
tyrosine kinase ZAP70 to the complex. Zap70 phosphorylates then the adaptor 
protein LAT that activates the MAPK and the Ras pathway, the latter enabling the 
activation of Erk and Creb. 
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accomplished according to the manufacturer’s protocol. Results for all data are presented as the 
average of three independent sets of experiments. To adjust for baseline changes between experiment 
days, mean fluorescence intensity for each protein assay across samples was normalized by the 
maximum value for the data. 
Figure 11 shows the signaling dynamics for 6 proteins of interest for lysates generated by the 




As illustrated in the simplified scheme of the TCR signaling cascade (Figure 10), the first proteins to 
be phosphorylated are CD3, Lck and Zap-70. Multiple signaling events occur before the downstream 
adaptor LAT, and the kinases Erk and CREB, are phosphorylated.  
With the device, phosphorylation of CD3, Lck and Zap-70 starts after 2 minutes of stimulation and 
reaches its peak at 3 minutes. In contrast, the phosphorylation of Erk rises concurrently with the 
Fig. 12 For each of the selected protein, comparison of the dynamics 
obtained with the microfluidic device and those obtained by standard bench 
top protocol. The dynamics are very similar and the microfluidic device 
shows a better consistency in the results. 
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downstream protein Creb over a longer period of 5 minutes. As expected, smaller variation occurs 
among samples across repeated experiments with the microfluidic device than with the manual 
stimulation and lysing, demonstrating a tight control over cell handling on-chip. The dynamic trends of 
activation are not dissimilar between the two experimental methods; however, an important feature 
emerges from the data. The uniformity of stimulatory exposure results in higher magnitudes of 
phosphorylation at early time points for all proteins measured. This is especially evident in the CD3 
ITAM phosphorylation, possibly due to a flattened distribution of stimulated cells in the manual 
bench-top samples arising from the time lag of  antibody:cell mixing. This feature highlights the 
necessity of consistent sample handling when quantifying cell population averages for signaling 
dynamics, especially when using small numbers of cells. 





 cells are needed per patient for adoptive transfer therapy, a number that creates 
significant challenges in generating with uniform responsiveness and specificity. As a result, a plethora 
of different methods have emerged for expanding T cells in vitro – soluble anti-CD3/CD28 (Riddell 
and Greenberg 1990), magnetic antibody-coated beads (Kalamasz et al 2004), HLA tetramer-bound 
beads (Maus et al 2003), dendritic cells (Ho et al 2006), and engineered antigen presenting cells (Maus 
et al 2002; Oelke et al 2003). In some cancer applications, tumor antigen-specific T cells are being 
primed in vivo, then derived and expanded ex vivo (Dang et al 2007). The non-uniformity and lack of 
standardization of the T cell expansion process prevents reproducibility and hinders clinical translation 
(Barber et al 2006).  
3.2.3.1 Methods 
Upon IRB approval, 30 mL of fresh blood was collected from 3 healthy donors, in EDTA coated tubes. 
After dilution 1:1 in a 0.9% NaCl solution, 30mL of diluted blood is layered on top of 15mL of density 
gradient medium, Lymphoprep, without mixing both liquids. After centrifugation at 800g for 20 
minutes, at 22°C, the peripheral blood mononuclear cells (PBMC) layer is removed with a 1mL 
pipette, leaving undisturbed the plasma layer (Figure 13).  




To remove platelets, this PBMC layer is washed twice with PBS, 0.1% BSA at 250g, for 10 minutes. 
The cells are then counted and resuspended in isolation buffer (PBS, 2mM EDTA) at 10
8 
cells/mL. A 
typical extraction process provides 40 to 70 millions of mononuclear cells. T cells are further extracted 
by depletion, using the T cell depletion kit from Invitrogen (Dynal Beads). After the extraction, the 
cells are washed and put in culture in flasks with 2 beads (anti-CD3, anti-CD28, expansion bead, 
Dynal Bead, Invitrogen) per cell, in regular medium at 10
6
 cells/mL. After 2 days of expansion, the 
cells are passaged and the medium is supplemented with 50U/mL of recombinant IL-2 (Sigma). The 
cells are then cultured for 2 weeks without restimulation, being passaged every two days and 
resuspended at 0.5⋅106 cells/mL.  
To ensure the cells were not subjected to any stress after bead removal, we monitored by 
flowcytometry the expression of phosphorylated ERK for several time points after bead removal 
(Figure 14). After bead removal, the cells were resuspended in IL-2 supplemented media, during the 
length of the experiment. The cells were fixed with a 2% paraformaldehyde solution, then 
permeabilized in a 90% methanol solution, before being frozen. The samples were then thawed and 
stained with a 100x rabbit-pERK antibody (eBiosciences) and a 500x RPE donkey anti-Rabbit 
secondary antibody was used for visualization purposes. After 2 hours, the cells have lost 20% of their 
Fig. 13 The peripheral blood mononuclear cell layer is obtained by centrifugation 
of diluted blood with a gradient density medium, here lymphoprep.  
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phosphorylated ERK. After 5 hours, only 60% of pERK is remaining. For all the following 
experiments, we have removed the beads at least 48 hours before the experiment to ensure no cross 
talk between the data obtained from the stimulation by our anti-CD3 antibody and the stimulation 
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For on-chip stimulation experiments, primary T-cells were resuspended in phenol-red and serum free 
medium, supplemented with 7% dextran. All the data were acquired with the same protocol than the 
one used for Jurkat Cells. 
3.2.3.2 Results and Discussion 
T cells from three healthy donors were extracted 6 days prior to the experiment. 
 
 
Fig. 14 The cells were fixed in 2% paraformaldehyde and stained for pERK. 
The activity of the activated ERK is normalized to the maximum activity at 
t=0 when the bead have just been removed. 









At day 6, 8 million cells for each donor were harvested and flown through the microfluidic chip with 
stimulus and lysis buffer. Quantification of the 6 phosphorylated proteins for the 3 donors showed a 
clear trend among the donors despite the variations from patient to patient (Figure 15). 








Division Rate  
(per day) * 
Donor 1 67 40 1.45 
Donor 2 38 24 1.74 
Donor 3 66 20 1.65 
Table 1 Characteristics of drawn blood from each donor. 




We then compared the dynamics of primary T cells and those obtained with Jurkat cells (Figure 16).  
Although there are some differences in the magnitude of the response, the activation times and the 
dynamic trends are conserved from the immortalized cell line to primary T cells. For example, peak 
phosphorylation of CD3 occurs at 3 minutes and peak activation of Erk occurs at 4 minutes across all 
samples. As all the protein activation data are normalized to their maximal value, we can see that the 
basal levels of LCK, ERK and LAT are higher in primary T cells than in the immortalized cell line. 
CREB seems to dephosphorylate immediately after it reaches its activation peak at 4minutes in 
primary T cells, whereas in Jurkat cells it stays active for at least one more minute.  
 
Fig. 15 For each of the selected protein, signaling dynamics are plotted for 
each of the three donors. The trends are very similar despite some 





3.3 Cell senescence determination 
3.3.1 Background 
Adoptive transfer therapy relies on large quantities of T cells that maintain effector function. Because 
the adoptive transfer of senescent cells will result in suboptimal outcomes, a standardized method that 
can quantitatively evaluate the sensitivity of T cells to antigenic cues will improve the consistency of 
immune-based therapies in cancer treatment.  
After a certain number of days of cultures, cells become anergic by senescence, and do not respond to 
antigenic cue. The production of IL-2 is decreased, and the levels of anti-apoptotic protein bcl-2 are 
low. Recently, Mazzati et al identified profilin-1, a ubiquitous protein associated with actin remodeling 
Fig. 16 Comparison between Jurkat cells in dashed lines and primary T cells from 
2 donors. Although there are some differences in the magnitude of the response, 
the activation times and the dynamic trends are conserved from the immortalized 
cell line to primary T cells. 
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and cellular motility, as an unambiguously identified protein that gets overexpressed in senescent T 
cells (2007).  
It has been shown that anergic T cells have a weakened TCR response. ERK and JNK are known to be 
dampened. The block in the pathway of MAPK occurs before RAS but it is not known exactly which 
protein plays the major role.( Howe et al 2003) 
 3.3.2 Methods, results and discussion 
Cell senescence could be observed in the regular culture. After 20 days of culture, without 
restimulation, the growth rate started to decrease, and the number of apoptotic bodies to increase in the 
culture medium. 
To obtain quantitative data of senescence, we used profilin-1 as a biomarker. Every third day, 2 
million cells from donor 3 were fixed with a 2% paraformaldehyde solution and 90% methanol and 
immunostained for profilin-1 (Cell Signaling). The levels of fluorescence of profiling were determined 
by flow cytometry (Figure 17). The data shown are the average of three different experiments. We 
observe a large increase on the 17
th




 day the levels of 
profilin are very low. This observation could be explained by the fact that cells started to die. The 
growth rate was almost null, and a quick experiment by flowcytometry showed two distinct 



















To demonstrate the feasibility of using the microfluidic chip to compare the responsiveness of short 
term versus long term cultured cells, we measured protein activation dynamics for cells from donor 3 
after 6 days and 16 days of culture. pCD3 and pZAP70 showed the maximal dampened response as 
shown in Figure 18. 
 
Fig. 17 Profilin is overexpressed in long term cultured cells. Primary T cells from 




Further investigations within the expansion methods and different culture time could enable the 
creation of a discriminanting model that could quickly assess the degree of senescence of a population. 
Protein activation data for different stages of culture, as well as profilin-1 expression and IL2 secretion 
would be the input data. 
3.4 A chip for fixing cells 
The microfluidic chip has been so far used to mix cells with stimulus and then lyse cells to perform 




































0 1 2 3 4 5 6
Early Passage (Day 6) Late Passage (Day 16) 
Fig. 18 The activation dynamics of pZAP70 and pCD3 are weaker in older cells. 8 millions cells 
from the same donor were flown through the microfluidic chip at day 6 and 16, and protein 
activation dynamics were quantified using the regular Luminex assay.    
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ways to observe some cellular behaviors, and it would be very interesting to take advantage of our 
quality stimulation resolution for use in other analysis techniques. Analysis of protein activation by 
flow cytometry requires a tedious fixing and staining process. Using the second module of the chip as 
a fixing module instead of a lysis module, we have progressed through an automation of the 
immunostaining process. To our knowledge, this is the first reported application of cell fixing on chip. 
3.4.1 Methods 
16 million T cells from donor 3 were harvested and resuspended in serum, phenol red free medium, 
supplemented with 7% dextran. Half of the cells were flowed through the microfluidic device with 
stimulus and lysis buffer. Lysates were collected, protein yield quantified with a BCA assay kit and 
phosphorylated proteins quantified with a Luminex based assay. The other half of the cells was flowed 
in another microfluidic device with stimulus and a 2% paraformaldehyde solution. It may be also 
possible to use the same chip to perform both lysis and fixing, by just exchanging syringes during the 
experiment and waiting for steady state before collecting to prevent cross-contamination of reagents. 
After collection of the fixed cells, they are centrifuged at 1500 rpm for 5 minutes, at 4°C, and 
resuspended in 90% methanol. As the method used later is based on single cell analysis, we did not 
perform any normalization to cell number. The fixed and permeabilized cells can then be stored at -
20°C before further experiments. We chose to compare the dynamics of pERK and pZAP70 by these 
two methods. We used 4 aliquots for the immunostaining, 2 for each protein 
3.4.2 Results and Discussion 
As shown in Figure 19, the dynamics observed with both methods correlates well with each other.  The 
minimum values seem to be lower with immunostaining. . We assumed that the cell distribution 
difference between the outlets was not broad enough to require a different concentrationantibodies and 
different volumes. Each sample was resuspended in 400 µl of methanol.  However, we know from the 
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predictability of the cell distribution that in outlets 4 and 5, which corresponds to the smaller time 
points, 30 seconds and 1 minute, that the cell concentration is lower. The dilution factor can maybe 




Fig. 19 The activation dynamics of pZAP70 and pERK were captured by lysing on chip and luminex 
bead based assay, and compared to the dynamics of these same proteins captured by fixing on chip 
and futher immunostaining. Both assays give very similar trends.    
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CHAPTER 4 
CONCLUSION AND FUTURE WORK 
Our device successfully accomplishes the tasks of multi-time point stimulation with on-chip cell 
lysis.  Rapid mixing, achieved with the staggered herringbone array, allows precise time point 
resolution down to 20 seconds. Modeling and confocal mixing experiments gave valuable insight 
into the mixing of solutions, with a wide range of fluidic properties relevant to biological 
experiments.  The flexible nature of this modular design allows easy adjustment of time points 
without changing the device or operation conditions.  This one-time-use device is inexpensive to 
fabricate, simple to set up, and simple to use.  The flexibility and potential for automation in the 
microfluidic format allows for future development for more “online” processing of samples, which 
may further reduce necessary sample volumes and cell concentrations.  From a single experiment, 
6 proteins were analyzed simultaneously for 8 timepoints, yielding 48 measurements from only 8 
million cells, only 5% of the amount needed in conventional methods. TCR signaling dynamics 
were acquired with a very good time resolution and low sampling error compared to manual 
pipetting. A comparison between Jurkat cells and primary T cells showed very similar trends 
among these two populations across the 6 proteins. The modularity of the device was demonstrated 
by the unlimited range of time points that can be acquired but also by the usability of the second 
module, as a fixing or lysing chip. Comparison of activation dynamics for cells fixed on chip and 
then immunostained, and cells lysed on chip, whose lysates were incubated with antibody capture 
beads, shows very similar trends, even with different capture antibodies.  
 
This microfluidic device also shows a great potential to study cell senescence. Adoptive transfer 
therapy requires a high quality expanded cell population before reintroduction into the patient. The 
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study of early signaling events in T cells with this device demonstrates excellent potential towards 
this goal. We have shown weakened protein activation after TCR ligation for long term cultured 
cells. A more in depth study of the magnitude of the activation state, correlated to biomarkers of 
senescence, such as the cytoskeleton protein profilin-1, or the magnitude of IL-2 secretion, can 
lead to the creation of a discriminant model enabling to assess quickly the state of senescence of a 
population. This study could include parameters such as type of expansion (IL-2 supplemented 
media only, IL-2 and CD3/CD28 beads), passage number, time of restimulation in culture, CD4+ 
vs CD8 T cells. This investigation could have a large impact on the clinical  feasibility of adoptive 









Parallel multi-time point cell stimulation and lysis on-chip for studying 
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Dynamics of complex signaling networks are important to many biological problems.  Quantitative 
data at early time points after cellular stimulation are necessary for accurate model generation.  
However, the large amount of data needed is often extremely time-consuming and expensive to 
acquire with conventional methods.  We present a two-module microfluidic platform for 
simultaneous multi-time point stimulation and lysis of T-Cells for early time point signaling 
activation with a resolution down to 20 seconds using only small amounts of cells and reagents. 
The key design features are rapid mixing of reagents and uniform splitting into 8 channels for 
simultaneous collection of multi-time point data.  Chaotic mixing was investigated via 
computational fluid dynamic modeling, and was used to achieve rapid and complete mixing.  This 
modular device is flexible - with easy adjustment of the setup, a wide range of time points can be 
achieved.  We show that treatment in the device does not elicit adverse cellular stress in Jurkat 
cells.  The activation of 6 important proteins in the signaling cascade was quantified upon 
stimulation with a soluble form of α-CD3.  The dynamics from device and conventional methods 
are similar, but the micro device exhibits significantly less error between experiments.  We 
envision this high-throughput format to enable simple and fast generation of large sets of 
quantitative data, with consistent sample handling, for many complex biological systems.
Introduction 
Understanding the dynamics of cell signaling networks is 
important to many biological applications, especially in 
complex disease phenotypes related to cancer, immune 
responses, development, and potential pharmacological 
interferences. Pathways involved in cell maintenance and 
apoptosis are studied extensively to understand cancer 
development1, 2.  Focus on particular signal-transduction 
cascades and molecules has provided system-level insights 
into mechanism-based drug discovery3, 4. Building a system-
level computational model and gaining insights in to the 
complex signaling networks requires large data sets, presently 
a bottleneck in the process.  For example, gene expression 
patterns or protein activity at various time points during 
stimulation with an external signal must be known; it usually 
takes many labs years to accumulate a large body of this type 
of data5-7.  Another challenge in signaling research is that 
many of these important protein activation events, such as 
phosphorylation, occur within minutes after stimulation8-10.  
Quantitative data not only at precise time points but early in 
the cells’ response are necessary for accurate model 
generation. 
 Intracellular immunostaining techniques via flow cytometry 
have proven useful for studying signaling pathways11; 
however the multi-laser cytometers are constrained for the 
number of proteins monitored. Cell lysis and biochemical 
detection of population averages remains the most widespread 
method of capturing intracellular signaling dynamics of 
protein pathways. To extract the necessary protein 
information the cell must be stimulated for a precise period of 
time and immediately lysed to extract intracellular proteins 
for downstream analysis.  With conventional, multi-well plate 
assays it is difficult to achieve adequate resolution at sub-
minute timescales.  Microfluidics is a capable alternative, 
providing uniformity in sample handling to reduce error 
between experiments.  Moreover, microfluidic systems require 
relatively small sample volumes for experiments, conserving 
valuable cells and reagents12.  Many microdevices have been 
reported for culturing cells, stimulating with soluble factors, 
assaying gene expression and performing lysis13-22.   
 The challenges of any on-chip assays are that the devices 
should minimize stress on the cells, should provide 
reproducible results from experiment to experiment, should 
produce quantitative results comparable to or better than 
bench-top schemes, should be scalable to high throughput 
format, should minimize consumption of cells and reagents, 
and ideally provide the temporal resolution that the bench-top 
counterparts cannot achieve. So far no chip-based designs 
have achieved all these criteria simultaneously.  Here we 
present a lab-on-a-chip platform for multiple time-point 
lymphocyte stimulation and lysis for downstream analysis of 
protein activation.  Mixing and even splitting of reagents into 
each time-point channel are key features of the design. 
 Previously El-Ali et al. developed a device achieving cell 
stimulus and lysis on a microfluidic chip using segmented 
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gas-liquid flow for rapid mixing16.  This device was the first 
to demonstrate on-chip multiple step manipulation of cells 
with fast mixing, thereby allowing access to the early time-
point detection of protein states.  For our application however, 
to understand over time how multiple proteins in the signaling 
network behave upon stimulation, vastly different incubation
  
Fig. 1 A schematic of the devices showing inlets, tubing, pressure drop channels and cell lysate outlets for sample collection.  The respective residence 
times (t) in each unit are noted in red boxes on the figure, where the total time is essentially the time in the tubings, varying with length (L),  inner 
diameter (ID) and volumetric flow rate (Q).  Insets (a) shows a close-up of Module 1 and (b) the whole device setup. 
periods are required. Therefore we have designed our device 
for 8 time points in parallel with controlled rapid mixing, 
precisely timed stimulation, and rapid lysis. In addition, in 
this work we also circumvent the large shear at the gas-liquid 
interface in the earlier work. We show that our assay platform 
does not induce stress responses to the cells and yields 
reproducible and quantitative protein activity information with 
small numbers of cells. 
Experimental Design 
In order to achieve precise incubation control on multiple time 
scales, we took a two-module approach for increased system 
flexibility (Figure 1).  In our design, pressure-driven flow (by 
syringe pumps) entered at only 3 inlets -- cells, stimulus and 
lysis buffer -- which made handling multiple samples and 
parallel experiments simple.  Cells and stimulus were mixed 
and split into 8 equal streams in less than 0.25 seconds on 
Module 1.  The majority of the incubation time (~20 seconds 
to 5 minutes in our experiments) occurred in the tubing 
leading to Module 2.  On Module 2 the reaction was quenched 
and cells were lysed by mixing with cold lysis buffer, in less 
then 1 second, to extract intracellular components.  Mixing 
and balancing flow-rates were important to the design, which 
we describe below. 
Rapid mixing to ensure precise stimulation times 
For precise definition of stimulation time, especially for the 
very early time points (e.g. 20 seconds), rapid mixing of cells 
with reagents was essential to our design.  Mixing is 
necessary in multiple steps of the assay: the cells first have to 
be mixed with the stimulant, and then once incubated for the 
desired duration they have to be mixed again with lysis buffer 
to yield lysate for downstream biochemical assays.  If mixing 
takes a significant portion of the time compared to stimulation 
and lysis incubation, cells suspended in the initial medium 
will be introduced to the stimulant at different times, and the 
contact time cannot be precisely controlled.  This non-
uniformity of contact time would make it difficult to define 
and repeat the “stimulation time”.   
 We considered a few existing designs of microfluidic 
mixers.  El-Ali et al have shown a gas/liquid segmented flow 
scheme to enhance mixing16.  The advantage of this mixing 
scheme is that it is very fast and the throughput is high; 
however, because the mixing scheme relies on the circulation 
of the liquid behind gas bubbles, the shear is large at the 
multiphase interface and can introduce undesired lysis and/or 
mechanotransduction in cells.  Ugaz et al.23 demonstrated 
Dean flow mixing, which is simple and could be suitable for 
many biological experiments since it is gentle.  However, for 
Dean flow mixers, better mixing correlates to higher 
Reynolds’ numbers ( µρ Lv ⋅⋅=Re  where ρ is the density of 
the fluid, µ the viscosity, v the linear velocity, and L the 
channel’s limiting dimension, is a measure of the inertial 
effect over viscous effect of fluid flow).  To implement this 
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mixing scheme for our application would require large flow 
rates that render the subsequent incubation step impractical.  
We chose the asymmetric herringbone mixer (HBM)24.  The 
mixing time in these devices are sufficiently short for our 
application and the shear is minimal.  There is no analytical 
solution to the mixing scheme, and a limited number of 
experiments have been performed on such mixer designs25-27.  
Optimized parameters, asymmetry of the herringbones (2/3 of 
the way across the channel) and angle with respect to y-axis 
(45o),  from Stroock et al. were used as a starting point in this 
design24.  
 In order to design proper mixers for our application and 
determine an accurate starting time of incubation, we 
developed computational fluid dynamics (CFD) models for 
different geometries and experimental flow conditions using 
COMSOL (Stockholm, Sweden), a finite element solver for 
non-linear partial differential equations.  Because our buffers, 
cell solutions, and stimulation solutions can have different 
fluidic properties, the model was also used to probe the 
mixing effects of viscosity and density.  Further confocal 
microscopy experiments were used to visualize the mixing of 
solutions with mismatched viscosity. 
Flow splitting and precisely-controlled stimulation 
After mixing, the fluid was split into 8 streams on Module 1.  
Each stream accomplished a different time point in the tubing 
leading to Module 2.  For efficient device operation, it was 
necessary for equal volumes of sample to be collected for 
each time point.  Equal flow rates in each stream were 
achieved by balancing the channel resistance.  The resistance, 
proportional to fluidic pressure drop and a function of channel 
dimensions, increases with increasing length and decreasing 













where ∆P is pressure drop, µ  is viscosity, Q is volumetric 
flow rate, L is path length, and d is the diameter,  we 






R ∝  (2) 
Since the microfluidic channels are square, when 












where h is the channel height and w is the channel width. This 
hydrodynamic diameter definition neglects the effect of 
channel shape,28 but suits our application in determining the 
order of magnitude resistance differences between tubing and 
channels.  All the lengths and widths of the are the same in 
each time point channel to achieve equal resistance. 
 The stimulation time is defined by residence time in the 
device.  This time is the sum of the residence time in the 
channels and the residence time in the tubing leading to the 











The subscripts c and t denote channels and tubing, 
respectively, and ID is the inner diameter.   
 This modular design, as shown in Figure 1, created a more 
flexible system by using interchangeable tubing of different 
lengths and diameters for multiple time point options. The 
majority of the incubation time occurred in the 
interchangeable tubing. However, the flow rates must not be 
influenced when changing lengths or diameters of tubing.  
This is inherent in out system design because of the small 
dimensions of the microfluidic channels and the d4 
dependence in the denominator in Equations 1 and 2.  In the 
worst case scenario with dimensions used in our experimental 
setup, the channel resistance was still four orders of 
magnitude greater than that of the tubings.  Furthermore, 
additional long pressure drop channels were added to increase 
this effect. Small variations in the channel dimensions in the 
PDMS molding should not effect our flow distribution and 
residence time predictions.  Since each time-point channel has 
the same dimensions, the major importance relies in the 
relative difference between the channels and tubing.  This 
order of magnitude effect will not be influenced by micron-
sized variations in the device fabrication process. To ensure 
this premise holds, the flow rates at each outlet were 
measured experimentally and validated. 
Materials and Methods 
Device Fabrication 
This two-module device was fabricated using standard soft 
lithographic techniques29.  Briefly the modules were molded 
in poly(dimethyl-siloxane) (PDMS) (Dow Corning Sylgard 
184, Essex-Brownwell Inc., McDonough GA) from a two-
layer SU-8 (Microchem Corp., Newton, MA) master.  One 
layer of 50 µm thick SU-8 2050 was spun onto 100-mm 
silicon wafer, baked, and exposed under UV light to define a 
negative image of the channel system in the resist.  After 
baking to crosslink the exposed resist, another layer of 15 µm 
thick SU-8 2010 was spun on top.  This layer formed the 
staggered herringbone array.  After the same bake and expose 
process, the wafers were developed using propylene glycol 
monomethyl ether acetate (Doe & Ingalls, Inc., Durham NC).  
The wafer was surface-treated with vapor-phase tridecafluoro-
1,1,2,2-tetrahydrooctyl-1-trichlorosilane (United Chemical 
Technologies, Inc, Bristol PA) for surface passivation. Then 
PDMS was cast on the SU-8 master and baked  for 2 hours at 
70 oC.  The PDMS was peeled off the mold and individual 
devices were cut to size.  Medical grade polyethylene (PE) 
tubing (Scientific Commodities, Lake Havasu City, AZ) of 
various lengths and inner diameters were used to for fluidic 
connections.  Holes for fluidic connections were punched to a 





A syringe pump (Harvard Apparatus PHD 2000 Series 
Infusion) controlled the flow to the 3 inlets at 28.22 µ L/min 
resulting in a 1/2 dilution of the stimulus and a 1/3 dilution of 
the lysis buffer.  Because of this, the stimulus and lysis buffer 
were delivered at 2x and 3x concentration, respectively.  The 
input cell concentration was ~8x106 cells/mL.  The resulting 
sample flow rates were 10.58 µL/min.  For negative control, 
cell culture medium was first used in the place of the 
stimulation solution.  After the start of the flow, the fluid was 
flushed to waste for 9 minutes before sample collection.  The 
time corresponded to that for the fluid front to get from the 
syringe to the end of the outlet tubing.  The sample lysate 
effluent was collected for approximately 15 minutes to obtain 
150 µL of sample, enough to perform all downstream 
analysis.  To stimulate the cells, the process was repeated, 
with 2 µg/mL OKT3 antiCD3 diluted in media in place of cell 
culture medium inlet. The total amounts of reagents used for 
all 8 time-point sample collections included only 1.35 mL of 
cell suspension and lysis buffer, and 0.68 mL of media and 
stimulus.  With improvements on the sensitivity of 
downstream analysis it is possible to collect far less lysate, 
thus conserving valuable sample. 
 Cells tend to settle over time because they are denser than 
the media that they are suspended in.  The settling in the 
syringes and tubings causes cell loss during experiments and 
unreliable time data.  Settling in the microfluidic channels 
causes the cells to roll along the bottom of the channel rather 
than follow the streamlines.  To resolve this issue, the media 
and stimulation solutions were supplemented with dextran of 
~70,000 MW (Sigma-Aldrich) to match the density of the 
cells (approx. 1.07 g/cm3).  The cell distribution after Module 
1 was characterized by using only Module 1 with one inlet 
flowing medium containing cells at a know concentration and 
the other medium, both supplemented with dextran.  The 
suspension in each outlet was collected and cells were counted 
to determine cell concentration. 
 
Confocal microscopy 
The confocal experiments were performed on a LSM 510 UV 
microscope (Carl Zeiss Inc) with a 20x  lens.  Rhodamine-B 
dye at 0.05 mg/mL was used in one of the two entering 
streams.  Inlets were perfused with the same flow rate as 
experimental conditions. The mismatch viscosity was created 
by using solutions of sucrose in water30. 
 Excitation was from a helium-neon laser (543 nm, 0.5 mW) 
and emission at 560 nm using a long pass wavelength filter 
optimized for Rhodmine-B.   The pixel time was 1.6 µs with 
2-µm slices in the z plane.  Confocal images were used to 
evaluate the extent of mixing.  After each cycle the standard 
deviation (σ) of intesity distributions of the channel 
crossections.  A σ value of 0.5 signifies completely unmixed 
streams while a 0 value signifies completely mixied streams. 
For figure clarity the brightness and contrast were increased in 
the same way for all x-y projections. 
 
Computational Fluid Dynamic Models for the Chaotic Mixer 
We modeled the transport and mixing in the HBM using the 
3-D Navier-Stokes equations for flow and the diffusion-
convection transport equation for the stimulant and the lysis 
buffer components at steady state.  These equations were 
solved using COMSOL.  Because of the asymmetry in the 
HBM, the model could not be reduced.  However, the Navier-
Stokes and convective diffusion equations can be decoupled 
and were solved separately.  The vector form of the Navier-
Stokes equations was as follows: 
 







ρµρ 2  (5) 
where ρ is the density, µ is the viscosity, u is the velocity vector, 
p is pressure, and F is a volume force field (gravity).   
 
Fig. 2 Comparison of COMSOL model results with experiment.  (a) 
perspective view of  the mixing for 1 cycle of herringbone mixers.  The 
slices are in the y-z plane perpendicular to the direction of flow.  (b) y-z 
plane of the concentration profile color map from the model after 1 cycle.  
Under the color map the z component of the herringbones are illustrated.  
(c) y-z view of a confocal image of mixing after 1 cycle with one inlet 
containing rhodamine dye.  (d) y-z mixing profile after 6 and 9 cycles.  
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The scale bar is 20 µm, twice the average diameter of a T-cell. 
(e) comparison of mixing profiles at in the cross section.  Each line 
represents the normalized concentration profile in the z direction at the 
designated distances in the y direction from the wall.  (f) standard 
deviation of concentration across each line in (e).   
 
 
This solver assumes incompressible flow ( 0=⋅∇ u ).  The 
boundary conditions were assigned as parabolic flow profiles 
at a given average velocity for the inlets, zero pressure at the 
outlet, and non-slip on all remaining exterior boundaries. The 
interior boundaries, were all assigned a neutral condition.  
These interior boundaries were created for enchanced 3-D 
mesh resolution by splitting the flow channel into 8 
subdomains and the herringbones into 6 subdomains each.  
This created additional nodes inside the subdomain while 
allowing a continous solution to the Navier-Stokes equations.  
The mesh density was such that further increases did not 
effect the convergence of the solution.  The final mesh 
consisted of 65,000 elements with average quality >0.3. 
 Then using the velocity field from the solution of the 
Navier-Stokes equations, the non-conservative convective 
diffusion equations were solved 






uδ  (6) 
where δts is the time-scaling coefficient, equal to 1 when 
solving in the seconds timescale (this term will drop out at 
steady state), c is the concentration, D is the diffusion 
coefficient (~1x10-11 m2/s for protein molecules31),  R is the 
reaction rate (set to zero in our model), and u is the 3-D 
velocity profile from the Navier-Stokes equations.  The 
boundary conditions were assigned as c = 1 and c = 0 at each 
inlet, convective flux at the outlet, and insulation at all 
remaining exterior boundaries.  The interior boundaries were 
all assigned a continuity condition. 
Cell Culture, Cell Lysis and Protein Analysis 
For this study, we used Jurkat E6-1 human acute T-cell 
lymphoma from ATCC (Manassas, VA, USA).  Cells were 
cultured in RPMI 1640 medium with L-glutamine (Sigma- 
Aldrich) with 10 mM HEPES, 1 mM Sodium Pyruvate, and 
1X MEM Nonessential Amino Acids, and 100 units/mL 
penicillin streptomycin (Cellgro), supplemented with 10% 
certified heat inactivated fetal bovine serum (Sigma-Aldrich) 
at 37 oC in a humidified 5% CO2 incubator.  For the 
experiments, Jurkat cells were resuspended in a phenol-red 
free RPMI 1640 medium (Sigma-Aldrich), supplemented with 
the previous reagents and 0.3 mg/ml of L-Glutamine (VWR) 
and 7 wt% dextran (Sigma-Aldrich). For the cell signaling 
experiments, the cells were treated with anti-human CD3, 
clone OKT3 (eBioscience) at a final concentration of 
2 µg/mL. The lysis buffer used in these experiments was 
based on a 1% NP-40 solution (USBiological), supplemented 
with 1 M β-glycerophosphate (Calbiochem), 0.2 M sodium 
pyrophosphate (Alpha Aesar), 1 M sodium fluoride (EMD), 
5 M Tris (Promega), 0.2 M sodium orthovanadate (Alfa  
  
Fig. 3 Comparison of mixing of different viscosity solutions. (a-b) Confocal images of the cross section at increasing mixing cycles of herringbones.  One 
inlet contains fluorescent rhodamine dye.  (a) y-z cross-sectional view of the mixing of two fluids with the same viscosity.  (b) y-z cross-sectional view of 
the mixing of two fluids with mismatched viscosity; the fluid with no fluorescent dye has a viscosity 20 times the other. (c) top view in the x-y plane of 
COMSOL data for density and viscosity mismatched solutions.  The viscosity and density values are based on the sucrose solutions used with 6x the 
viscosity of  water. 
Aesar), 5 M sodium chloride (Alfa Aesar), 100 mM 
benzamidine (Sigma), 500 mM EGTA (VWR), 5 mg/ml 
aprotinin (Sigma), 5 mg/ml leupeptin (VWR), 1 mg/ml 
pepsatin (Sigma), 1 mg/ml microcystin-LR (Sigma). For 
device-mediated cell lysing, lysis buffer at 0 °C was directly 
mixed with the cell suspension in Module 2 and lysate 
solution collected at the outlets of the device in 
microcentrifuge tubes. For standard bench lysing, the addition 
was made by pipette addition of lysis buffer to 
microcentrifuge tubes containing the cells. For both forms of 
lysing, the samples were incubated on ice for 10-30 minutes, 
centrifuged at 14,000 rpm for 10 minutes and the supernatants 
were used for further analysis. The total protein concentration 
after lysis was determined with a BCA assay kit32 and results 
were obtained after protein content between samples was 
diluted to uniform levels. 
Stress and Signaling 
All analysis of phosphorylation dynamics were performed 
with a Bio-Plex-200 instrument (Bio-Rad) using commercially 
available Luminex bead assays. The phospho-JNK and 
phospho-p38 measurements (BioRad) or the quantification of 
proteins downstream of TCR (Beadlyte 7-plex Human T-Cell 
Receptor Signaling Kit, Millipore) were completed according 
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to manufacturers’ protocols. Results for all data are presented 
as the average of three independent sets of experiments. To 
adjust for baseline changes between experiment days, mean 
fluorescence intensity for each protein assay across samples 
was normalized by the maximum value for the data. 
 
Results and Discussion 
Analysis of rapid mixing by microscopy and computational 
methods 
The CFD modeling results and confocal images from 
experiments are shown in Figure 2.  In the confocal images 
(Figure 2 c and d), the bright fluorescent fluid is analogous to 
a stimulus rich solution and the dark areas is analogous to 
fluid with no stimulus.  The experimentally determined 
profiles are similar to those by Stroock et al. under the same 
conditions.  More importantly, the computational model 
agrees well with experimental data (Figure 2 e and f); hence 
the models can be used as a tool to probe the mixing 
properties and factors that may influence the extent of mixing 
to optimize our experimental conditions.  Experimental results 
for mixing of solutions with the same viscosity (mimicking 
cell and stimulus mixing conditions) suggest that most cells 
would come into contact with the stimulus after 6 cycles 
because the widths of the stimulus-negative solution stream 
are smaller than the cell diameter (~ 10 µm); the standard 
deviation of mixing is 0.14.  After 9 cycles the solutions are 
completely mixed with a standard deviation of 0.05.   
 In contrast, when solutions with mismatched viscosity and 
density are mixed (as in the case of mixing cell suspension, 
µ ~ 4.3cP and ρ = 1.07g/cm3, with lysis buffer,µ ~ 2.4 cP and 
ρ = 1.06 g/cm3) with the same HBM, as seen in Figure 3, the 
streamline profiles and hence the extent of mixing are 
qualitatively different.  In this case, the mixing is slower and 
less efficient, marked by incomplete mixing after 9 cycles in a 
mixing of solutions of 20 times viscosity mismatch.  The 
standard deviation was 0.12.  Although the viscosity and 
density of fluids are correlated in most cases, we can separate 
the two effects in the numerical simulations.  Our models 
suggest that less effective mixing is mainly due to the 
mismatch in viscosity, not the difference in density, because 
the more viscous solution has a lower average velocity and 
therefore takes up more cross-sectional area (Figure 3c). This 
results in the fluid interface moving beyond the point of 
asymmetry (2/3 of the way across the channel) of the 
herringbones, reducing the effectiveness of the herringbones’ 
ability to stretch, fold, and mix the two fluids.  However, this 
effect occurs only at viscosity ratio of 6:1 and above for the 
current HBM design.  Because we use dextran-supplemented 
solutions, we stay below the 6:1 viscosity ratio and therefore 
the HBM is adequate for fast mixing of cells and stimulus in 
Module 1, and of cells and lysis buffer in Module 2. 
 The model was also used to characterize the shear stress at 
the walls.  At the channel wall, the highest shear stress is 
~6 Pa and the highest shear stress at the herringbone wall is 
~1.8 Pa.  These numbers are on the same order as the in the 
blood, with maximum shear stress of approximately 4 Pa.33  
Tight control of stimulation times in multiple parallel samples  
Based on the channel dimensions and fluid flow rates of the 
optimized setup, the staggered herringbone array achieved full 
mixing of reagents with minimal shear in less than 
0.2 seconds on the stimulation chip (Module 1), and <0.9 
seconds on the lysis chip (Module 2).  These times are less 
than 5 percent of the ~23-second stimulation time, which was 
the shortest stimulation time in our experiments.  Hence the 
mixing time does not significantly affect our time point data. 
 Taylor dispersion, caused by diffusion and the parabolic 
flow profile, could be important for the cell stimulation time.    
 
Fig. 4 Demonstration of device uniformity.  (a) Equal flowrates in µL/min 
across the different channels.  The channels are noted with the 
corresponding stimulation time in minutes.  The dashed line indicates the 
set flow rate (total/number of channels) and error bars indicate standard 
deviation. (b) The average standard deviation of cell concentration in each 
stream with and without dextran supplement in the solutions.  The 
standard deviation between experiments is decreased by half with the 
addition of dextran and percent cell loss is markedly decreased. 
With a diffusion coefficient on the order of 10-10 cm2/s (from 
Stokes-Einstein’s equation), the modified Peclet number (ratio 
of the shortest residence time to the timescale for dispersion) 
is on the order of 105, suggesting that Taylor dispersion in the 
tubing will introduce errors in the stimulation/incubation time.  
However as we demonstrate in the protein signaling 
experiments in this work, the time points resolve easily and a 
trend can be quantified.  If necessary, further experiments to 
determine the true residence time distribution can be used to 
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deconvolve such time-series data, or an alternative incubation 
strategy can be used. For example, mutliple chips with long 
channels of different volumes and also with integrated 
herringbone structures can be used in place of tubing, and may 
tighten the residence time distribution of the samples.  
Flow resistance balance to achieve equal distribution of fluids 
The flow rate in each outlet was characterized as described in 
the experimental methods section.  Figure 4a shows the flow 
rates across different time points with varying tubing 
dimensions.  Error bars represent the standard deviation from 
trial to trial, which demonstrates the repeatability from device 
to device.  The flat trend and tight standard deviation around 
the target 8.3 µL/min flow rate demonstrates the reliability of 
the device flow rates even while varying length, widths, and 
thus resistance of the tubing (as shown it Table 1) between 
Modules 1 and 2 for each point.  The highest pressure drops in 
the tubing is 66 Pa, as compared to 18 kPa in the microfluidic 
channels.  The advantage is that this configuration provides 
large flexibility of the specific time points for stimulation we 
can achieve.  With commercially available tubings, we can 
easily achieve stimulation times of ranging from ~20 seconds 
to 1 hour. 
Table 1 Example tubing dimensions for given time points and the 
pressure drop (analogous to resistance) for each tubing. 
Time point/min Tubing ID/mm Tubing Length/cm ∆P/Pa 
0.5 280 4.2 66.4 
1 380 4.7 21.9 
1.5 580 3 2.6 
2 580 4.1 3.5 
2.5 580 5.2 2.6 
3 580 6.2 3.1 
4 580 8.3 4.2 
5 580 10.4 5.3  
 
Reliable cell distribution after stimulation and reliable 
protein yield after lysis 
Without adding dextran to the cell suspension, cells were 
often observed to settle and aggregate; these aggregations in 
turn cause blockage on chips and together with settling cause 
the cell distribution in the 8 collected samples to be non-
uniform and unpredictable.  In comparison, reliable cell 
distribution between experiments was achieved by adding 
dextran to the solutions for density matching.  In addition, 
dextran may also contribute to the suppression of non-specific 
adsorption of serum proteins in the medium, which promotes 
cell adhesion to the device walls.    As shown in Figure 4b, 
the average standard deviation of cell density in each stream 
was decreased by more than half.  These data were obtained 
by flowing cells through the device at a known density, but 
replacing the stimulus and lysis solutions with media, and 
counting intact cells from each outlet.  In addition, by taking 
the cells lost (Figure 4c) to settling in the syringes and devices 
into account, the resulting improvement by adding dextran is 
very significant.  Although variability between cell 
concentrations per stream still exists, protein activity data can 
be easily normalized by the total protein in the sample.  We 
have verified that the total protein yield is linearly correlated 
to the number of cells in the sample (data not shown). 
On-chip cell handling showing minimal stress on cells 
For a microfluidic device to perform optimally for signal 
transduction applications, fluid forces must not impose 
adverse stresses on the cells within the chip. To validate that 
the cells flowing through the device were not subjected to 
undesirable shear stress due to fluid flow in narrow channels, 
undesirable mechanical forces produced by chaotic mixing, or 
lack of oxygen perfusion during the course of the experiment, 
the phosphorylation state of two MAPK proteins associated 
with stress response, p38 and JNK, were monitored. Cells in 
dextran-supplemented medium (no stimulatory reagents) were 
pumped through Module 1 and lysed in Module 2. The lysates 
were compared to the results from cells lysed by an analogous 
bench-top protocol (also without any stimulation). As shown 
in Figure 5, the levels of p38 and pJNK activation for the on- 
chip experiment are constant over time and comparable to the 
results obtained on bench, demonstrating that the cells are 
neither adversely stressed by the conditions imposed by flow 
through the microchannels, nor stressed by the time spent in 
the tubings.  There was no noticeable change in cell viability 
or morphology as observed by trypan blue exclusion after 




Fig. 5 Activated JNK and p38 concentrations in cells collected from the 
microfluidic devices compared to on bench controls, showing now signs 
of cellular stress induced by the device. For this experiment, samples 
were normalized to total cellular protein content. The experiments were 
run with three different devices and then the protein phosphorylation 
quantification was obtained with duplicates. Dashed lines represent the 
quantified values for phospho-p38 and phospho-JNK from control 
samples lysed on the bench. Dotted lines indicate standard deviation 
associated with the control values.  Mean fluorescence intensity 
measurements for positive controls were comparable in magnitude to 
positive control lysates supplied by the manufacturer (data not shown). 
Parallel on-chip experiments for high-throughput multi-time 
point protein activation assays 
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The temporal regulation of protein activation during T-Cell 
receptor signaling involves multiple coordinated feedback 
loops, as reviewed by Germain et al.10. Prior proteomic 
studies indicate widespread phosphorylation of signaling 
molecules occur within 5 minutes of T-Cell activation34; thus, 
a method for consistent generation of sub-minute signaling 
events would be useful for extracting relationships between 
interconnected network components. To ensure that the 
microfluidic system is a reliable method of evaluating T-Cell 
activation, we characterized the phosphorylation dynamics of 
representative signaling molecules downstream of the T-Cell 
receptor (Figure 6a).  Comparisons between anti-CD3 (OKT3) 
stimulated Jurkat lysates generated by standard bench-top 
protocol and those generated by the device were made using 
the Beadlyte 7-plex human T-Cell receptor phosphoprotein 
signaling kit (Upstate). This kit quantifies phosphorylated 
ITAMs (CD3ε), ZAP-70, Lck, LAT, Erk, and CREB using the 
Luminex instrument as described by Khan et al 35. Jurkat cells 
in a 7% dextran medium were stimulated with the soluble 
form of anti-CD3 for the incubation times ranging 
approximately from 20 seconds to 4.5 minutes and then lysed 
with a cold lysis buffer containing phosphatase and protease 
inhibitors that prevent further biochemical events after lysis. 
Figures 6b-6g show the signaling dynamics for these 6 
proteins of interest for lysates generated by the microfluidic 
device and for lysates generated on bench. As illustrated in 
the simplified scheme of the TCR signaling cascade (Figure 
6a), the first proteins to be phosphorylated are CD3, Lck and 
Zap-70. Multiple signaling events occur before the 
downstream adaptor LAT, and the kinases Erk and CREB, are 
phosphorylated.  




Fig. 6 (a) Simplified pathway of TCR activation. After a peptide MHC has bound to the CD3/TCR complex , Lck phosphorylates the 
ITAM CD3, that recruits the tyrosine kinase ZAP70 to the complex. Zap70 phosphorylates then the adaptor protein LAT that activates 
the MAPK and the Ras pathway, the latter enabling the activation of Erk and Creb. In our case, we used OKT3 that specifically reacts 
with the CD3 complex.  (b-f) For each of the selected protein, comparison of the dynamics obtained with the microfluidic device and 
those obtained by standard bench top protocol. The dynamics are very similar and the microfluidic device shows a better consistency 
in the results. 
 With the device, phosphorylation of CD3, Lck and Zap-70 starts after 2 minutes of stimulation and reaches its 
peak at 3 minutes. In contrast, the phosphorylation of Erk rises concurrently with the downstream protein Creb 
over a longer period of 5 minutes. As expected, smaller variation occurs among samples across repeated 
experiments with the microfluidic device than with the manual stimulation and lysing, demonstrating a tight 
control over cell handling on-chip. The dynamic trends of activation are not dissimilar between the two 
experimental methods; however, an important feature emerges from the data. The uniformity of stimulatory 
exposure results in higher magnitudes of phosphorylation at early time points for all proteins measured. This is 
especially evident in the CD3 ITAM phosphorylation, possibly due to a flattened distribution of stimulated cells 
in the manual bench-top samples arising from the time lag of antibody:cell mixing. This feature highlights the 
necessity of consistent sample handling when quantifying cell population averages for signaling dynamics, 
especially when using small numbers of cells. 
Conclusions 
Our device successfully accomplishes a multi-time point stimulation experiment with on-chip cell lysis.  Rapid 
mixing, achieved with the staggered herringbone array, allows precise time point resolution down to 20 seconds. 
Modeling and confocal mixing experiments gave valuable insight into the mixing of solutions, with a wide range 
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of fluidic properties, relevant to biological experiments.  The flexible nature of this modular design allows easy 
adjustment of time points without changing the device or operation conditions.  This one-time-use device is 
inexpensive to fabricate, simple to set up, and simple to use.  The flexibility and potential for automation in the 
microfluidic format allows for future development for more “online” processing of samples, which may further 
reduce necessary sample volumes and cell concentrations.  From a single experiment, 6 proteins were analyzed 
simultaneously for 8 timepoints, yielding 48 measurements from only 10 million cells, only 5% of the amount 
needed in conventional methods7. We expect a high-throughput format of this device coupled with multiplexed 
biochemical analysis to yield large sets of quantitative data for reconstructing signaling networks in many 
applications.  
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